Biosearch Seeks to Enter IVD Market with Expanded Roche License | GenomeWeb

Biosearch Technologies has taken an important step toward entering the in vitro diagnostics market by expanding its license with Roche Molecular Systems in the area of nucleic acid amplification technologies, the company said this week.

Under the new license, Novato, Calif.-based Biosearch now has the right to manufacture and sell validated kits to the IVD marketplace as licensed products covered by multiple patents assigned to Roche.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.